Multi-wavelength anomalous dispersion

Multi-wavelength anomalous diffraction (sometimes Multi-wavelength anomalous dispersion; abbreviated MAD) is a technique used in X-ray crystallography that facilitates the determination of the three-dimensional structure of biological macromolecules (e.g., DNA, drug receptors) via solution of the phase problem.[1] This method can be applied in cases where two crystal structures exist -- one structure for which one or more atoms has been replaced by heavy-atoms (in order to cause significant anomalous scattering from incoming X-rays) and one for which no heavy-atom replacement has been made. The most commonly used heavy atom used for phase determination is selenium: Selenomethionine is a heavy-atom derivative of the amino acid methionine, which can be inserted through the use of selective media during protein expression. Anomolous diffraction is then recorded at different wavelengths of coherent X-ray light at a synchrotron facility.

MAD was developed by Wayne Hendrickson while working as a postdoctoral researcher under Jerome Karle at the United States Naval Research Laboratory. [2] The mathematics upon which MAD (and progenitor Single-wavelength Anomalous Diffraction) were based were developed by Jerome Karle, work for which he was awarded the 1985 Nobel Prize in Chemistry (along with Herbert Hauptman).

Contents

See also

Anomalous Dispersion

Isomorphous Replacement

Two methods for providing the needed phasing information by introducing heavy atoms into isomorphous crystals:

Other

References

  1. ^ Hendrickson W, Ogata C (1997). "Phase determination from multiwavelength anomalous diffraction measurements". Meth Enzymol. Methods in Enzymology 276: 494–523. doi:10.1016/S0076-6879(97)76074-9. ISBN 9780121821777. 
  2. ^ Hendrickson WA (1985). "Analysis of Protein Structure from Diffraction Measurement at Multiple Wavelengths". Trans. ACA 21. 

Further reading

External links

Computer programs

Tutorials and examples